Hepatocellular carcinoma: Treatment potential of targeting Toll-like receptors in HCC

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 9, 2014, Pages 518-

  Leake, Isobel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIPROLIFERATIVE ACTIVITY; CANCER INHIBITION; CELL PROLIFERATION; HUMAN; INNATE IMMUNITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR XENOGRAFT; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MOLECULAR TARGETED THERAPY; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 84906854776     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.129     Document Type: Note

References (1)

1. Original article Mohamed, F E. et al. Effect of Tolllike receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. doi:10.1111/liv.12626